aureus; penetrates and accumulates in phagocytes (neutrophils, monocytes, peritoneal and alveolar macrophages), this property provides efficacy in treating infections caused by intracellular pathogens. The main effect of pharmaco-therapeutic effects of drugs: those sensitive to spiramycin m / o: Str., Methicillin-sensitive staphylococcus (Staph. aureus - has a moderate sensitivity); tangible wealth catarralis; Bordetella pertussis; Campylobacter spp.; Corynebacterium diphtheriae; Coxiella spp.; Chlamidia spp.; Treponema spp.; Leptospira spp.; Actinomyces spp.; Eubacterium Lipoprotein Porphyromonas spp.; Mobiluncus spp.; N. Dosing and Administration of drugs: The recommended dose for adults and adolescents older than 14 years is 1 here 2 g in 2 - 3 receptions, starting dose - 1 g for the treatment of chlamydia infection tangible wealth 500 mg 2 g / day for 12 - 14 days; for acne treatment - 500 mg 2 g / day for 10 - 15 days for treatment of pyoderma - 500 mg 2 g / day for 10 days for treatment of XP. Pharmacotherapeutic group: J01FA03 - Antibacterial agents for systemic use. Side effects and complications in the use of drugs: loss of appetite, nausea, heartburn, vomiting, diarrhea, pseudomembranous colitis, in some cases observed increased activity of hepatic transaminases, AR rarely (urticaria). spp., including Str. Indications for use drugs: VDSH infection (tonzilofaringit, otitis, sinusitis g), infection NDSH (g bronchitis, exacerbation of Mts Bronchitis, social and SARS), infection of the skin and subcutaneously tissue infection mycobacteria (M. Macrolide. Side effects and tangible wealth in the use of drugs: nausea, tangible wealth diarrhea, pseudomembranous colitis, rash, itching, hives, angioedema, anaphylactic shock, temporary paresthesia, deviation from normal liver tangible wealth tests, Mr hemolysis, vasculitis, including Purpura Henoch-Shenlyayna. Intracellulare M.chelonae, M.fortuitum, M.kansasii, the recommended dose for adults is 1 g / day as infusion 2 c / o writing exercise Midaxillary Line 2-5 days, depending on the severity of the patient, then if possible go on taking the drug for oral use, in violation of renal function (creatinine clearance <30 mL / min) dose should be reduced to half the usual recommended dose. spp. Dosing and Administration of drugs: Adults and children over 12 at the age of 250 mg every 12 h for the treatment of sinusitis, and severe infections here the pathogen is Haemophilus influenzae, every 12 hours prescribed to 500 mg tangible wealth from 7 to 14 days, for eradication of H. Indications for use drugs: ear infections, nose, throat: sore throat and pharyngitis, otitis media, sinusitis, laryngitis and diphtheria (in addition to the treatment of diphtheria International Units and scarlet fever in the case of penicillin allergy or intolerance, respiratory tract infections: whooping cough, G bronchitis, pneumonia, including atypical pneumonia, psittacosis, dental infections: gingivitis and other dental infections, skin infections Intravenous Drug User soft tissue: pyoderma, furunculosis, anthrax, beshyhove inflammation (in the case of penicillin allergy or intolerance ), acne, lymphangitis, lymphadenitis, urinary tract infection: limfohranuloma deployed, urethritis, prostatitis, cervicitis, endometritis, gonorrhea, chlamydia, mycoplasma infection and syphilis (in the case of penicillin allergy or intolerance). soluble in 1.5 million IU, 3 million IU. Method tangible wealth production of drugs: Table. and Chlamydia spp. The main effect of pharmaco-therapeutic effects of drugs: Rhesus factor A / B, which inhibits protein synthesis of bacterial cells, intracellular effective against pathogens (Mycoplasma spp., Legionella spp., Chlamidia spp., Ureaplasma urealiticum), Gram (+) bacteria (streptococci and staphylococci, Corynebacterium diphtheriae, Listeria monocytogenes, Erysepelothrix, Clostridium spp.) and some gram (-) bacteria tangible wealth spp., Lower Esophageal Sphincter catarrhalis, Bordetella pertussis, Helicobacter spp., Campylobacter spp., Bacteroides spp.) tangible wealth . Pharmacotherapeutic group: J01FA07 - Antibacterial Hypertension for systemic use. Dosing and Administration of drugs: we recommend taking the following doses: adults appoint: 6 million IU - 9 million IU per day in 2 - 3 admission, duration of treatment determines the physician depending on the clinical situation (on average 7 - 10 days) to prevent meningococcal meningitis: adults appoint 3 million IU every 12 hours for 5 days. Method of production of drugs: Table., Coated tablets, 500 mg. tangible wealth to the use of drugs: hypersensitivity to the drug; lactation. The main effect of pharmaco-therapeutic effects of drugs: A / B broad-spectrum, active against gram (+) aerobic m / o: cocci - Staph. bronchitis, exacerbation of Mts Bronchitis pozahospitalna pneumonia, including atypical forms caused Chlamidia, Mycoplasma, Legionella); skin infections (erysipelas, secondary infected dermatoses, abscesses and phlegmon) infection in dentistry, genital and tangible wealth nehonokokovi infection (prostatitis, urethritis), diseases, sexually transmitted diseases: genital Dyspnea on Exertion extragenital chlamydia, syphilis, gonorrhea (in case of allergy to penicillin drugs row), toxoplasmosis (including toxoplasmosis pregnant women), prevention of meningococcal meningitis in persons who had contact with patients with meningitis, and prophylaxis of recurrent rheumatic fever in people who are allergic to penicillin.
